TerSera Therapeutics

Business news, market intelligence, and global industry analysis.

The Latest

Palantir Technologies (NASDAQ: PLTR) expands Asia enterprise push through LG CNS partnership

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Representative image of the United States Strategic Petroleum Reserve and oil infrastructure as the Trump administration authorises a 172 million barrel SPR drawdown while 32 International Energy Agency nations coordinate the largest emergency oil release in history to stabilise global crude markets.

Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release

IBM Corporation and Lam Research Corporation launch five-year collaboration to enable sub-1nm semiconductor logic scaling

The sub-1nm race is heating up and IBM and Lam Research just made their move

Representative image showing an oil tanker under attack in the Strait of Hormuz as tensions involving Iran’s Islamic Revolutionary Guard Corps raise fears of a major supply disruption that analysts warn could push global oil prices toward $200 per barrel.

Iran: Get ready for $200 oil. IRGC fires on more ships in the Gulf

TerSera Therapeutics real-world ziconotide data at ASPN 2025 shows rising guideline-based intrathecal pain therapy adoption

TerSera Therapeutics highlights real-world ziconotide prescribing trends at ASPN 2025, signaling growing guideline-aligned adoption in chronic pain management.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

July 19, 2025